Caribou Biosciences Inc (CRBU) — Financial Flexibility Index
Caribou Biosciences Inc (CRBU) has a Financial Flexibility Index of -0.36x as of December 2025. Free cash flow of $-20.61 Million (operating CF $-20.82 Million minus capex $216.00K) represents 0% of total liabilities ($57.46 Million). Check Caribou Biosciences Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Caribou Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Caribou Biosciences Inc across 7 annual periods. See Caribou Biosciences Inc (CRBU) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Caribou Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Caribou Biosciences Inc. For the full company profile including market capitalisation, see Caribou Biosciences Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.06x | $-109.63 Million | $-110.99 Million | $53.19 Million | ▲ +5.5% |
| 2024 | -2.18x | $-131.69 Million | $-138.20 Million | $60.36 Million | ▼ -70.4% |
| 2023 | -1.28x | $-81.68 Million | $-93.29 Million | $63.81 Million | ▼ -10.4% |
| 2022 | -1.16x | $-84.51 Million | $-90.97 Million | $72.89 Million | ▼ -115.1% |
| 2021 | -0.54x | $-29.40 Million | $-32.52 Million | $54.53 Million | ▼ -0.5% |
| 2020 | -0.54x | $-31.90 Million | $-33.22 Million | $59.48 Million | ▲ +6.1% |
| 2019 | -0.57x | $-31.12 Million | $-32.01 Million | $54.47 Million | — |